UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or oth ...

Universal Health Services, Inc. (NYSE:UHS) Q3 2020 Earnings Conference Call October 30, 2020 10:00 AM ET Company Participants Steve Filton - Executive Vice President & Chief Financial Officer Alan Miller - Chairman & Chief Executive Officer Marc Miller - President Conference Call Participants Andrew Mok - Barclays Matthew Borsch - BMO Capital Markets Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Sarah James - Piper Sandler Pito Chickering - Deutsche Bank Ralph Giacobbe - Citi Josh Raskin - Nep ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or other ju ...

Universal Health Services, Inc. (NYSE:UHS) Q2 2020 Earnings Conference Call July 28, 2020 9:00 AM ET Company Participants Steve Filton - CFO Alan Miller - CEO Conference Call Participants Andrew Mok - Barclays Eugene Kim - Wolfe Research Pito Chickering - Deutsche Bank Kevin Fishbeck - Bank of America Brent Kasser - JPMorgan A.J. Rice - Credit Suisse Operator Ladies and gentlemen, thank you for standing by. I would now like to hand the conference over to your speaker today Mr. Steve Filton. Thank you. Pleas ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or other j ...

Universal Health Services, Inc. (NYSE:UHS) Q1 2020 Earnings Conference Call April 28, 2020 9:00 AM ET Company Participants Steve Filton - CFO Alan Miller - CEO Marc Miller - President Conference Call Participants Andrew Mok - Barclays Eugene Kim - Wolfe Research Eric Glenn - BMO Capital Markets Pito Chickering - Deutsche Bank Frank Morgan - RBC Capital Markets Kevin Fishbeck - Bank of America Matthew Gillmor - Baird David Cohen - JPMorgan Whit Mayo - UBS Chris Neamonitis - Piper Sandler A.J. Rice - Credit ...

Universal Health Services, Inc. (NYSE:UHS) Q4 2019 Earnings Conference Call February 27, 2020 9:00 AM ET Company Participants Steve Filton - Executive Vice President and Chief Financial Officer Conference Call Participants Andrew Mok - Barclays Capital Matthew Borsch - BMO Capital Markets Eugene Kim - Wolfe Research Kevin Fishbeck - Bank of America Merrill Lynch A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Sarah James - Piper Sandler Josh Raskin - Nephron Research LLC Matthew Gillmor - Robert W ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) Delaware 23-2077891 (State or other jurisdict ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or other jurisdiction of incorporation or organization) (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 1 ...